Clinical Trial Update: Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on the combination of tivantinib with pemetrexed and carboplatin in malignant pleural mesothelioma and nonsquamous non-small cell lung ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Nonsquamous Non-small Cell Lung Neoplasm

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)
• tivantinib (tivantinib)

Snippet

Sponsor: Armando Santoro, MD | Conditions: Malignant Pleural Mesothelioma, Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 1, Phase 2 | Status: COMPLETED